Frost & Sullivan releases the 'Research Report on the Current Development and Future Trends of the CDMO Industry'

Under the trend of innovative R&D, competition in the pharmaceutical industry is becoming increasingly fierce. The division of labor within the pharmaceutical supply chain is gradually becoming specialized, refined, and customized. CDMOs, leveraging their technical advantages and production capabilities, assist pharmaceutical companies in transitioning from concept to product, from process development to large-scale production. Entrusting CDMO services has become an important path for innovative R&D and production. Both start-ups and large pharmaceutical companies can benefit from the high-quality services provided by CDMOs. CDMOs also continuously optimize their technical platforms, expand business scope, and extend the industrial chain to meet the actual needs of different types of customers in keeping with the ever-changing pharmaceutical market. Frost & Sullivan (Frost & Sullivan, abbreviated as "Frost & Sullivan") hereby releases the "Research Report on the Current Development Status and Future Trends of the CDMO Industry".